Efficacy and safety of neoadjuvant chemoradiotherapy plus apatinib for patients with locally advanced, HER2-negative, Siewert's type II-III adenocarcinoma of esophagogastric junction: a single-arm, open-label, phase II trial

This study aimed to investigate the efficacy and safety of concurrent neoadjuvant chemoradiotherapy (CRT) plus apatinib in treating locally advanced, HER2-negative, Siewert’s type II-III adenocarcinoma of esophagogastric junction (AEG) patients. Thirty eligible patients were analyzed in this single-...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	American journal of translational research 2021-01, Vol.13 (8), p.9015-9023
Hauptverfasser:	Guo, Honghai, Li, Yong, Lin, Chi, Cheng, Yunjie, Zhang, Zhidong, Wang, Dong, Zhao, Xuefeng, Liu, Yu, Jing, Shaowu, Yang, Peigang, Tian, Yuan, Liu, Yang, Wang, Jun, Zhao, Qun
Format:	Artikel
Sprache:	eng
Schlagworte:	Original
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!